Intervals Lengthened, Costs Lowered By HPV DNA Primary Screening – ACS
This article was originally published in The Gray Sheet
Executive Summary
Cervical cancer screening with human papillomavirus DNA tests in conjunction with cytology is sufficiently sensitive to permit widened screening intervals, the American Cancer Society finds Nov. 15